Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of GBP 170.91 billion. The enterprise value is 190.14 billion.

Market Cap	170.91B
Enterprise Value	190.14B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	Mar 12, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-2.90%
Shares Change (QoQ)	-1.25%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.87B

Valuation Ratios

The trailing PE ratio is 17.17 and the forward PE ratio is 14.14.

PE Ratio	17.17
Forward PE	14.14
PS Ratio	4.15
PB Ratio	5.74
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.72, with an EV/FCF ratio of 13.95.

EV / Earnings	19.10
EV / Sales	4.50
EV / EBITDA	10.72
EV / EBIT	13.49
EV / FCF	13.95

Financial Position

The company has a current ratio of 0.79, with a Debt / Equity ratio of 0.81.

Current Ratio	0.79
Quick Ratio	0.50
Debt / Equity	0.81
Debt / EBITDA	1.40
Debt / FCF	1.78
Interest Coverage	16.83

Financial Efficiency

Return on equity (ROE) is 32.89% and return on invested capital (ROIC) is 16.23%.

Return on Equity (ROE)	32.89%
Return on Assets (ROA)	11.42%
Return on Invested Capital (ROIC)	16.23%
Return on Capital Employed (ROCE)	25.98%
Revenue Per Employee	542,853
Profits Per Employee	131,159
Employee Count	75,883
Asset Turnover	0.55
Inventory Turnover	2.24

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+12.02%
50-Day Moving Average	110.91
200-Day Moving Average	109.17
Relative Strength Index (RSI)	68.05
Average Volume (20 Days)	275

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of GBP 41.19 billion and earned 9.95 billion in profits. Earnings per share was 4.94.

Revenue	41.19B
Gross Profit	31.18B
Operating Income	13.74B
Pretax Income	11.55B
Net Income	9.95B
EBITDA	17.09B
EBIT	13.74B
Earnings Per Share (EPS)	4.94

Full Income Statement

Balance Sheet

The company has 5.52 billion in cash and 24.20 billion in debt, giving a net cash position of -18.68 billion.

Cash & Cash Equivalents	5.52B
Total Debt	24.20B
Net Cash	-18.68B
Net Cash Per Share	n/a
Equity (Book Value)	29.76B
Book Value Per Share	15.16
Working Capital	-5.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 14.71 billion and capital expenditures -1.08 billion, giving a free cash flow of 13.63 billion.

Operating Cash Flow	14.71B
Capital Expenditures	-1.08B
Free Cash Flow	13.63B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.68%, with operating and profit margins of 33.35% and 24.16%.

Gross Margin	75.68%
Operating Margin	33.35%
Pretax Margin	28.03%
Profit Margin	24.16%
EBITDA Margin	41.50%
EBIT Margin	33.35%
FCF Margin	33.08%

Dividends & Yields

This stock pays an annual dividend of 2.61, which amounts to a dividend yield of 2.21%.

Dividend Per Share	2.61
Dividend Yield	2.21%
Dividend Growth (YoY)	5.34%
Years of Dividend Growth	3
Payout Ratio	60.27%
Buyback Yield	2.90%
Shareholder Yield	5.12%
Earnings Yield	5.82%
FCF Yield	7.97%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.71.

Altman Z-Score	3.71
Piotroski F-Score	n/a